DK0983270T3 - Fremgangsmåde til fremstilling af 6-O-monoestere af castanospermin - Google Patents

Fremgangsmåde til fremstilling af 6-O-monoestere af castanospermin

Info

Publication number
DK0983270T3
DK0983270T3 DK98919929T DK98919929T DK0983270T3 DK 0983270 T3 DK0983270 T3 DK 0983270T3 DK 98919929 T DK98919929 T DK 98919929T DK 98919929 T DK98919929 T DK 98919929T DK 0983270 T3 DK0983270 T3 DK 0983270T3
Authority
DK
Denmark
Prior art keywords
castanospermine
monoesters
preparation
Prior art date
Application number
DK98919929T
Other languages
English (en)
Inventor
Christian T Goralski
Sandra Stolz-Dunn
David H Louks
Brian D Scherzer
Mark A Nitz
Mark R Smit
James E Hitt
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0983270T3 publication Critical patent/DK0983270T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
DK98919929T 1997-05-22 1998-04-27 Fremgangsmåde til fremstilling af 6-O-monoestere af castanospermin DK0983270T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86187497A 1997-05-22 1997-05-22
PCT/US1998/008471 WO1998052947A1 (en) 1997-05-22 1998-04-27 Process for preparing 6-o-monoesters of castanospermine

Publications (1)

Publication Number Publication Date
DK0983270T3 true DK0983270T3 (da) 2004-05-10

Family

ID=25337000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98919929T DK0983270T3 (da) 1997-05-22 1998-04-27 Fremgangsmåde til fremstilling af 6-O-monoestere af castanospermin

Country Status (20)

Country Link
EP (1) EP0983270B1 (da)
JP (1) JP2002502374A (da)
KR (1) KR20010012790A (da)
CN (1) CN1111531C (da)
AR (1) AR012712A1 (da)
AT (1) ATE259808T1 (da)
AU (1) AU739675B2 (da)
BR (1) BR9809657A (da)
CA (1) CA2287316C (da)
DE (1) DE69821757T2 (da)
DK (1) DK0983270T3 (da)
ES (1) ES2212292T3 (da)
HK (1) HK1025323A1 (da)
HU (1) HUP0004095A3 (da)
IL (1) IL133000A0 (da)
NO (1) NO314038B1 (da)
NZ (1) NZ500639A (da)
TW (1) TW467911B (da)
WO (1) WO1998052947A1 (da)
ZA (1) ZA984180B (da)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis

Also Published As

Publication number Publication date
DE69821757T2 (de) 2005-01-13
DE69821757D1 (de) 2004-03-25
ES2212292T3 (es) 2004-07-16
ZA984180B (en) 1998-11-23
JP2002502374A (ja) 2002-01-22
HK1025323A1 (en) 2000-11-10
CN1257501A (zh) 2000-06-21
AU7260898A (en) 1998-12-11
BR9809657A (pt) 2000-07-11
AR012712A1 (es) 2000-11-08
CA2287316A1 (en) 1998-11-26
NO995698L (no) 2000-01-21
IL133000A0 (en) 2001-03-19
TW467911B (en) 2001-12-11
HUP0004095A2 (hu) 2001-06-28
NO995698D0 (no) 1999-11-19
WO1998052947A1 (en) 1998-11-26
AU739675B2 (en) 2001-10-18
NZ500639A (en) 2001-08-31
EP0983270A1 (en) 2000-03-08
CN1111531C (zh) 2003-06-18
HUP0004095A3 (en) 2002-06-28
CA2287316C (en) 2005-02-08
EP0983270B1 (en) 2004-02-18
NO314038B1 (no) 2003-01-20
ATE259808T1 (de) 2004-03-15
KR20010012790A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
DK1032566T5 (da) Fremgangsmåde til fremstilling af citalopram
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK0790226T3 (da) Fremgangsmåde til fremstilling af methanol
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK1036179T4 (da) Fremgangsmåde til fremstilling af polypeptider med egnet glycosilering
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DK0905254T3 (da) Fremgangsmåde til fremstilling af en lavemolekylær
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0966444T3 (da) Fremgangsmåde til fremstilling af pyrazolderivater
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK2281892T3 (da) Fremgangsmåde til fremstilling af respiratorisk-deficiente Trichoderma-celler
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer